Brainstorm Cell Therapeutics Inc.
BCLI
$1.00
$0.011.01%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -10.52M | -9.57M | -10.31M | -10.85M | -11.45M |
| Total Depreciation and Amortization | 179.00K | 184.00K | 199.00K | 204.00K | 215.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.91M | 1.12M | 1.70M | 1.45M | 1.08M |
| Change in Net Operating Assets | 3.37M | 1.61M | 1.43M | 1.91M | 676.00K |
| Cash from Operations | -4.06M | -6.66M | -6.98M | -7.28M | -9.48M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 12.00K | 12.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 12.00K | 12.00K |
| Total Debt Issued | 862.00K | 862.00K | 1.48M | 900.00K | 900.00K |
| Total Debt Repaid | 74.00K | -900.00K | -900.00K | -1.10M | -1.10M |
| Issuance of Common Stock | 2.31M | 4.63M | 4.35M | 5.41M | 5.09M |
| Repurchase of Common Stock | -1.00K | -1.00K | -1.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 450.00K | 1.95M | 1.95M | 1.95M |
| Cash from Financing | 3.24M | 5.04M | 6.88M | 7.16M | 6.85M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -816.00K | -1.62M | -95.00K | -113.00K | -2.62M |